Literature DB >> 7173131

Autonomic dysfunction in epilepsy: characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity.

C M Lathers, P L Schraeder.   

Abstract

The purpose of this study was to determine if epileptogenic activity is associated with changes in autonomic cardiac neural discharge and the development of arrhythmias. Nine cats, anesthetized with alpha-chloralose, received pentylenetetrazol (PTZ), 10, 20, 50, 100, 200, and 2,000 mg/kg, intravenously at 10 min intervals. The following were monitored: neural discharge from 1 to 3 postganglionic cardiac sympathetic branches (8 cats, 17 nerves) and the vagus (7 cats, 8 nerves); the electrocorticogram; blood pressure; heart rate; and lead II electrocardiogram. Autonomic dysfunction was manifested by: the observation that autonomic cardiac nerves did not always respond in a predictable manner to changes in blood pressure; the development of a marked increase in variability in mean autonomic cardiac sympathetic and parasympathetic neural discharge; and the fact that the very large increase in the variability of the discharge rate of parasympathetic nerves was seen after PTZ, 50 mg/kg, but did not develop until 100 mg/kg in sympathetic neural discharge. This autonomic imbalance was associated with both interictal and ictal epileptogenic activity. Almost invariably, interictal discharge occurred after PTZ, 10 mg/kg; with higher doses, the duration of ictal activity increased although interictal discharges were present. The altered cardiac autonomic neural discharge was associated with minimal epileptogenic activity in the form of interictal discharges and cardiac arrhythmias which may contribute to sudden unexplained death of the epileptic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173131     DOI: 10.1111/j.1528-1157.1982.tb05079.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Early seizure detection in rats based on vagus nerve activity.

Authors:  Kristian R Harreby; Cristian Sevcencu; Johannes J Struijk
Journal:  Med Biol Eng Comput       Date:  2010-10-02       Impact factor: 2.602

Review 2.  Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome.

Authors:  H Mitsumoto; M J Schwartzman; M L Estes; S M Chou; E F La Franchise; P De Camilli; M Solimena
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

3.  Ictal Asystole in Focal Epilepsy: To Pace or Not to Pace?

Authors:  Christopher R Newey; Aarti Sarwal
Journal:  Neurohospitalist       Date:  2015-10

4.  Ictal and peri-ictal changes in cervical vagus nerve activity associated with cardiac effects.

Authors:  Kristian R Harreby; Cristian Sevcencu; Johannes J Struijk
Journal:  Med Biol Eng Comput       Date:  2011-05-05       Impact factor: 2.602

Review 5.  Cardiac dysfunction during seizures and the sudden epileptic death syndrome.

Authors:  S Oppenheimer
Journal:  J R Soc Med       Date:  1990-03       Impact factor: 18.000

Review 6.  Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?

Authors:  Thaddeus Walczak
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 7.  Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death.

Authors:  A M Davis; B H Natelson
Journal:  Tex Heart Inst J       Date:  1993

Review 8.  Cardiovascular manifestations of autonomic epilepsy.

Authors:  Roy Freeman
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

9.  Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus.

Authors:  Yong-Zhi San; Yu Liu; Yu Zhang; Ping-Ping Shi; Yu-Lan Zhu
Journal:  Mol Med Rep       Date:  2015-04-17       Impact factor: 2.952

10.  Epilepsy: Indian perspective.

Authors:  Nandanavana Subbareddy Santhosh; Sanjib Sinha; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.